Symbols / COSM Stock $0.21 -9.69% Cosmos Health Inc.

Healthcare • Medical Distribution • Greece • NCM
COSM (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Distribution
CEO Mr. Grigorios Siokas
Exch · Country NCM · Greece
Market Cap 12.79M
Enterprise Value 28.07M
Income -21.13M
Sales 69.49M
FCF (ttm) -11.26M
Book/sh 0.40
Cash/sh 0.01
Employees 163
Insider 10d —
IPO Jul 23, 2010
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E 2.94
PEG —
P/S 0.18
P/B 0.52
P/C —
EV/EBITDA -1.70
EV/Sales 0.40
Quick Ratio 0.63
Current Ratio 1.08
Debt/Eq 87.87
LT Debt/Eq —
EPS (ttm) -0.66
EPS next Y 0.07
EPS Growth —
Revenue Growth 30.70%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-05-22
Earnings (prior) 2026-05-22
ROA -18.71%
ROE -92.32%
ROIC —
Gross Margin 10.40%
Oper. Margin -12.18%
Profit Margin -30.41%
Shs Outstand 62.08M
Shs Float 40.26M
Insider Own 32.17%
Instit Own 5.10%
Short Float 1.98%
Short Ratio 0.88
Short Interest 890.29K
52W High 1.32
vs 52W High -84.39%
52W Low 0.20
vs 52W Low 5.64%
Beta 4.12
Impl. Vol. 25.00%
Rel Volume 2.83
Avg Volume 1.41M
Volume 4.00M
Target (mean) $4.50
Tgt Median $4.50
Tgt Low $4.50
Tgt High $4.50
# Analysts 1
Recom Strong_buy
Prev Close $0.23
Price $0.21
Change -9.69%
About

Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, the United Arab Emirates, Albania, North Macedonia, and Cyprus. The company provides prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It offers ASTO-CHOL (Pravastatin), Diorium (Omeprazole), HEART-FREE (Clopidogrel), LIPICHOL (Atorvastatin), Miltus (Donepezil), Newzypra (Olanzapine), PNEUMO-KAST (Montelukast), Sahar (Pioglitazone), VIVALCID (Leucovorin), and Diabit-is (Sitagliptin). In addition, the company offers branded biocides and antiseptic soaps under the C-Sept and C-Scrub brand names; and other pharmaceutical products include Melatonin Spray, used to reduce insomnia and jet lag; Otikon ear drops, which is a Class II medical device in the form of ear drops; and baby foods, such as organic powder milk, pasta with minced meat, whole grain rice cereals, whole grain cereal porridges, and organic rice creams with vanilla milk, as well as pear, carrot and banana purée under the Bio-bebe brand. It serves wholesalers and retail healthcare providers. The company was founded in 2009 and is headquartered in Thessaloniki, Greece.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$4.50
Mean price target
2. Current target
$0.21
Latest analyst target
3. DCF / Fair value
$-3.27
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.21
Low
$4.50
High
$4.50
Mean
$4.50
News
RSS: Latest COSM news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-02-12 SIOKAS GRIGORIOS Chief Executive Officer — 388,532 $0.37 $145,000
2026-02-11 SIOKAS GRIGORIOS Chief Executive Officer — 291,262 $0.41 $120,000
2026-01-23 SIOKAS GRIGORIOS Chief Executive Officer — 90,325 $0.50 $45,000
2026-01-20 SIOKAS GRIGORIOS Chief Executive Officer — 353,321 $0.50 $175,000
2026-01-14 SIOKAS GRIGORIOS Chief Executive Officer — 493,495 $0.45 $220,000
2026-01-12 SIOKAS GRIGORIOS Chief Executive Officer — 113,185 $0.50 $57,000
2026-01-08 SIOKAS GRIGORIOS Chief Executive Officer — 156,190 $0.52 $81,000
2026-01-07 SIOKAS GRIGORIOS Chief Executive Officer — 124,880 $0.52 $65,000
2026-01-06 SIOKAS GRIGORIOS Chief Executive Officer — 133,953 $0.54 $72,000
2025-12-19 SIOKAS GRIGORIOS Chief Executive Officer — 88,314 $0.49 $43,000
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
65.27
+19.93%
54.43
+1.97%
53.38
+6.02%
50.35
Operating Revenue
65.27
+19.93%
54.43
+1.97%
53.38
+6.02%
50.35
Cost Of Revenue
57.38
+14.49%
50.12
+2.22%
49.03
+10.45%
44.39
Reconciled Cost Of Revenue
57.38
+14.49%
50.12
+2.22%
49.03
+10.45%
44.39
Gross Profit
7.90
+83.14%
4.31
-0.88%
4.35
-26.98%
5.96
Operating Expense
24.44
+24.90%
19.56
-25.27%
26.18
+94.93%
13.43
Research And Development
0.52
-2.61%
0.53
+223.48%
0.16
—
Selling General And Administration
22.55
+26.80%
17.78
-30.00%
25.40
+91.82%
13.24
Selling And Marketing Expense
0.15
-57.68%
0.35
-70.53%
1.20
+91.19%
0.63
General And Administrative Expense
22.40
+28.52%
17.43
-27.98%
24.20
+91.86%
12.61
Salaries And Wages
6.78
+19.05%
5.69
+25.00%
4.55
+87.52%
2.43
Other Gand A
15.62
+33.12%
11.73
-40.26%
19.64
+92.89%
10.18
Total Expenses
81.81
+17.41%
69.68
-7.35%
75.21
+30.07%
57.82
Operating Income
-16.54
-8.44%
-15.25
+30.13%
-21.83
-192.09%
-7.47
Total Operating Income As Reported
-16.70
-7.45%
-15.54
+28.80%
-21.83
-192.09%
-7.47
EBITDA
-15.15
-8.85%
-13.92
+18.41%
-17.06
-91.68%
-8.90
Normalized EBITDA
-16.95
-25.42%
-13.51
+34.48%
-20.62
-117.66%
-9.47
Reconciled Depreciation
1.37
+9.62%
1.25
+103.33%
0.61
+225.26%
0.19
EBIT
-16.52
-8.91%
-15.17
+14.17%
-17.68
-94.46%
-9.09
Total Unusual Items
1.79
+535.98%
-0.41
-111.55%
3.56
+521.75%
0.57
Total Unusual Items Excluding Goodwill
1.79
+535.98%
-0.41
-111.55%
3.56
+521.75%
0.57
Special Income Charges
-0.09
+67.75%
-0.29
-108.71%
3.35
+233.75%
1.00
Other Special Charges
-0.07
—
-1.91
-90.31%
-1.00
Impairment Of Capital Assets
0.16
-44.25%
0.29
0.00
—
Restructuring And Mergern Acquisition
—
0.00
+100.00%
-1.44
0.00
Net Income
-19.14
-18.30%
-16.18
+12.73%
-18.54
-34.07%
-13.83
Pretax Income
-19.14
-18.30%
-16.18
+12.73%
-18.54
-42.03%
-13.06
Net Non Operating Interest Income Expense
-2.23
-267.45%
-0.61
-197.55%
-0.20
+94.54%
-3.73
Interest Expense Non Operating
2.62
+159.07%
1.01
+16.83%
0.87
-78.15%
3.97
Net Interest Income
-2.23
-267.45%
-0.61
-197.55%
-0.20
+94.54%
-3.73
Interest Expense
2.62
+159.07%
1.01
+16.83%
0.87
-78.15%
3.97
Interest Income Non Operating
0.40
-2.47%
0.41
-38.68%
0.66
+180.46%
0.24
Interest Income
0.40
-2.47%
0.41
-38.68%
0.66
+180.46%
0.24
Other Income Expense
-0.38
-16.54%
-0.32
-109.29%
3.49
+288.52%
-1.85
Other Non Operating Income Expenses
-2.17
-2601.84%
0.09
+231.69%
-0.07
+97.28%
-2.42
Gain On Sale Of Security
1.89
+1684.27%
-0.12
-157.56%
0.21
+147.89%
-0.43
Tax Provision
0.00
0.00
0.00
-100.00%
0.78
Tax Rate For Calcs
0.00
0.00
0.00
-100.00%
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
-100.00%
0.13
Net Income Including Noncontrolling Interests
-19.14
-18.30%
-16.18
+12.73%
-18.54
-34.07%
-13.83
Net Income From Continuing Operation Net Minority Interest
-19.14
-18.30%
-16.18
+12.73%
-18.54
-34.07%
-13.83
Net Income From Continuing And Discontinued Operation
-19.14
-18.30%
-16.18
+12.73%
-18.54
-34.07%
-13.83
Net Income Continuous Operations
-19.14
-18.30%
-16.18
+12.73%
-18.54
-34.07%
-13.83
Normalized Income
-20.94
-32.75%
-15.77
+28.64%
-22.10
-54.80%
-14.28
Net Income Common Stockholders
-19.14
+14.45%
-22.38
+13.21%
-25.78
+59.68%
-63.95
Otherunder Preferred Stock Dividend
0.00
-100.00%
6.20
-14.45%
7.24
-82.57%
41.55
Diluted EPS
-0.63
+46.15%
-1.17
+45.58%
-2.15
+93.52%
-33.16
Basic EPS
-0.63
+46.15%
-1.17
+45.58%
-2.15
+93.52%
-33.16
Basic Average Shares
30.29
+58.19%
19.15
+59.98%
11.97
+520.73%
1.93
Diluted Average Shares
30.29
+58.19%
19.15
+59.98%
11.97
+520.73%
1.93
Diluted NI Availto Com Stockholders
-19.14
+14.45%
-22.38
+13.21%
-25.78
+59.68%
-63.95
Depreciation Amortization Depletion Income Statement
1.37
+9.62%
1.25
+103.33%
0.61
+225.26%
0.19
Depreciation And Amortization In Income Statement
1.37
+9.62%
1.25
+103.33%
0.61
+225.26%
0.19
Preferred Stock Dividends
—
—
—
8.56
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
65.48
+20.56%
54.31
-17.73%
66.01
-2.97%
68.04
Current Assets
38.39
+50.77%
25.46
-30.45%
36.61
-35.05%
56.37
Cash Cash Equivalents And Short Term Investments
0.76
+126.57%
0.34
-91.27%
3.85
-81.44%
20.76
Cash And Cash Equivalents
0.72
+127.12%
0.32
-91.78%
3.83
-81.53%
20.75
Cash Financial
0.72
+127.12%
0.32
-91.78%
3.83
-81.53%
20.75
Other Short Term Investments
0.05
+118.26%
0.02
+5.34%
0.02
+34.90%
0.01
Receivables
22.56
+42.06%
15.88
-26.86%
21.71
-20.20%
27.21
Accounts Receivable
19.63
+45.63%
13.48
-31.79%
19.76
-16.60%
23.69
Gross Accounts Receivable
50.27
+38.58%
36.28
-8.03%
39.45
+27.24%
31.00
Allowance For Doubtful Accounts Receivable
-30.65
-34.42%
-22.80
-15.81%
-19.69
-169.33%
-7.31
Loans Receivable
0.49
-58.39%
1.17
+37.18%
0.85
+6.13%
0.80
Inventory
5.78
+32.67%
4.36
-9.06%
4.79
+38.74%
3.45
Prepaid Assets
—
—
—
—
Restricted Cash
2.74
0.00
—
—
Other Current Assets
6.54
+33.84%
4.89
-21.81%
6.25
+26.49%
4.94
Total Non Current Assets
27.09
-6.10%
28.85
-1.89%
29.41
+151.95%
11.67
Net PPE
11.78
-5.00%
12.40
-8.10%
13.49
+360.52%
2.93
Gross PPE
13.90
+1.63%
13.67
-5.37%
14.45
+279.49%
3.81
Accumulated Depreciation
-2.12
-66.10%
-1.28
-33.20%
-0.96
-9.05%
-0.88
Properties
0.00
0.00
0.00
0.00
Land And Improvements
3.77
+13.38%
3.32
-6.43%
3.55
0.00
Buildings And Improvements
5.30
+17.15%
4.53
-5.46%
4.79
0.00
Machinery Furniture Equipment
3.62
+16.42%
3.11
+5.61%
2.95
+34.43%
2.19
Construction In Progress
0.60
-70.00%
2.00
+0.00%
2.00
0.00
Other Properties
0.60
-15.38%
0.71
-38.83%
1.16
+4.27%
1.11
Leases
0.00
+13.39%
0.00
-6.43%
0.00
-99.28%
0.50
Goodwill And Other Intangible Assets
7.57
-2.41%
7.76
-0.65%
7.81
+1004.46%
0.71
Goodwill
0.05
+0.00%
0.05
+0.00%
0.05
+0.00%
0.05
Other Intangible Assets
7.52
-2.42%
7.71
-0.66%
7.76
+1080.42%
0.66
Non Current Deferred Assets
—
—
—
0.00
Non Current Deferred Taxes Assets
—
—
—
0.00
Other Non Current Assets
4.59
+57.33%
2.92
+176.00%
1.06
+170.14%
0.39
Total Liabilities Net Minority Interest
47.05
+58.01%
29.78
-0.64%
29.97
+5.60%
28.38
Current Liabilities
38.27
+48.59%
25.76
+5.90%
24.32
+11.83%
21.75
Payables And Accrued Expenses
17.41
+37.66%
12.65
+2.75%
12.31
+14.60%
10.74
Payables
16.63
+33.79%
12.43
+2.33%
12.14
+16.02%
10.47
Accounts Payable
14.62
+31.07%
11.16
-6.33%
11.91
+17.54%
10.13
Current Accrued Expenses
0.79
+254.57%
0.22
+33.35%
0.17
-39.63%
0.28
Total Tax Payable
—
—
0.00
-100.00%
0.13
Current Debt And Capital Lease Obligation
13.74
+40.85%
9.76
+14.29%
8.54
+2.81%
8.31
Current Debt
13.52
+41.55%
9.55
+16.10%
8.23
+2.30%
8.04
Other Current Borrowings
4.33
+69.46%
2.55
+61.27%
1.58
-30.25%
2.27
Current Capital Lease Obligation
0.23
+8.53%
0.21
-33.44%
0.31
+18.27%
0.26
Other Current Liabilities
7.11
+112.35%
3.35
-3.57%
3.47
+28.59%
2.70
Total Non Current Liabilities Net Minority Interest
8.78
+118.36%
4.02
-28.82%
5.65
-14.83%
6.63
Long Term Debt And Capital Lease Obligation
6.23
+201.87%
2.06
-46.92%
3.89
+4.46%
3.72
Long Term Debt
5.85
+275.01%
1.56
-48.59%
3.04
+6.15%
2.86
Long Term Capital Lease Obligation
0.37
-25.57%
0.50
-40.97%
0.85
-1.16%
0.86
Other Non Current Liabilities
2.56
+30.45%
1.96
+11.08%
1.76
-39.46%
2.91
Stockholders Equity
18.42
-24.90%
24.53
-31.93%
36.04
-9.11%
39.66
Common Stock Equity
18.42
-24.90%
24.53
-31.93%
36.04
-8.25%
39.28
Capital Stock
0.04
+73.73%
0.02
+48.21%
0.02
-95.83%
0.38
Common Stock
0.04
+73.73%
0.02
+48.21%
0.02
+50.70%
0.01
Preferred Stock
0.00
0.00
0.00
-100.00%
0.37
Share Issued
41.15
+73.72%
23.69
+48.22%
15.98
+50.70%
10.61
Ordinary Shares Number
41.07
+73.99%
23.60
+48.48%
15.90
+50.10%
10.59
Treasury Shares Number
0.09
+0.00%
0.09
+0.00%
0.09
+458.15%
0.02
Additional Paid In Capital
152.14
+7.45%
141.58
+9.75%
129.01
+14.97%
112.21
Retained Earnings
-133.17
-16.79%
-114.02
-24.42%
-91.64
-38.37%
-66.23
Gains Losses Not Affecting Retained Earnings
0.33
+115.53%
-2.13
-408.51%
-0.42
+62.93%
-1.13
Treasury Stock
0.92
+0.00%
0.92
+0.00%
0.92
+12.30%
0.82
Other Equity Adjustments
0.33
+115.53%
-2.13
-408.51%
-0.42
+62.93%
-1.13
Total Equity Gross Minority Interest
18.42
-24.90%
24.53
-31.93%
36.04
-9.11%
39.66
Total Capitalization
24.28
-6.96%
26.09
-33.23%
39.08
-8.09%
42.52
Working Capital
0.12
+139.30%
-0.30
-102.41%
12.29
-64.51%
34.62
Invested Capital
37.80
+6.04%
35.64
-24.65%
47.30
-5.74%
50.18
Total Debt
19.97
+68.94%
11.82
-4.86%
12.42
+3.32%
12.03
Net Debt
18.65
+72.80%
10.80
+45.34%
7.43
—
Capital Lease Obligations
0.60
-15.57%
0.71
-38.95%
1.16
+3.41%
1.12
Net Tangible Assets
10.85
-35.30%
16.78
-40.58%
28.24
-27.51%
38.95
Tangible Book Value
10.85
-35.30%
16.78
-40.58%
28.24
-26.81%
38.58
Current Notes Payable
0.01
+13.38%
0.01
-6.43%
0.01
+3.40%
0.01
Duefrom Related Parties Current
2.44
+98.65%
1.23
+11.94%
1.10
-59.45%
2.71
Dueto Related Parties Current
2.00
+57.75%
1.27
+448.19%
0.23
+12.76%
0.21
Interest Payable
0.79
+254.57%
0.22
+33.35%
0.17
-39.63%
0.28
Line Of Credit
9.18
+31.39%
6.99
+5.35%
6.63
+15.13%
5.76
Non Current Note Receivables
3.15
-45.52%
5.77
-18.08%
7.05
-7.78%
7.64
Other Equity Interest
—
-0.00
+0.00%
-0.00
+100.00%
-4.75
Preferred Stock Equity
—
—
—
0.37
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-8.45
-9.47%
-7.72
+50.65%
-15.64
-5.15%
-14.87
Cash Flow From Continuing Operating Activities
-8.45
-9.47%
-7.72
+50.65%
-15.64
-5.15%
-14.87
Net Income From Continuing Operations
-19.14
-18.30%
-16.18
+12.73%
-18.54
-34.07%
-13.83
Depreciation Amortization Depletion
1.37
+9.62%
1.25
+103.33%
0.61
+225.26%
0.19
Depreciation
1.37
+9.62%
1.25
+103.33%
0.61
+225.26%
0.19
Depreciation And Amortization
1.37
+9.62%
1.25
+103.33%
0.61
+225.26%
0.19
Other Non Cash Items
3.34
+1056.67%
0.29
+129.60%
-0.98
-151.48%
1.90
Stock Based Compensation
2.31
+36.84%
1.69
+192.37%
0.58
+2268.47%
0.02
Asset Impairment Charge
6.05
+18.70%
5.09
-57.03%
11.85
+110.80%
5.62
Deferred Tax
0.02
+291.86%
-0.01
-101.80%
0.66
-15.78%
0.78
Deferred Income Tax
0.02
+291.86%
-0.01
-101.80%
0.66
-15.78%
0.78
Operating Gains Losses
-1.59
—
-1.91
-123.47%
-0.86
Gain Loss On Investment Securities
-1.53
—
-0.00
-116.71%
0.02
Unrealized Gain Loss On Investment Securities
-0.02
-765.10%
-0.00
+46.12%
-0.00
-173.51%
-0.00
Change In Working Capital
-0.78
-587.18%
0.16
+102.02%
-7.90
+9.13%
-8.69
Change In Receivables
-6.11
-596.29%
1.23
+130.58%
-4.03
+46.01%
-7.46
Changes In Account Receivables
-6.11
-596.29%
1.23
+130.58%
-4.03
-24.11%
-3.24
Change In Inventory
-0.83
-666.73%
0.15
+116.44%
-0.89
-83.51%
-0.49
Change In Prepaid Assets
-0.89
+64.43%
-2.51
-68.21%
-1.49
-17.54%
-1.27
Change In Payables And Accrued Expense
5.01
+349.35%
1.12
+136.29%
0.47
+265.09%
-0.29
Change In Accrued Expense
0.55
+689.10%
0.07
+159.71%
-0.12
+87.33%
-0.91
Change In Payable
4.47
+326.93%
1.05
+78.04%
0.59
-6.29%
0.63
Change In Account Payable
4.47
+326.93%
1.05
+46.04%
0.72
-58.68%
1.73
Change In Other Current Assets
—
—
—
0.00
Change In Other Current Liabilities
2.04
+1047.47%
0.18
+109.08%
-1.96
-343.00%
0.81
Investing Cash Flow
-2.01
-152.40%
-0.80
+94.20%
-13.76
-63910.59%
-0.02
Cash Flow From Continuing Investing Activities
-2.01
-152.40%
-0.80
+94.20%
-13.76
-63910.59%
-0.02
Net PPE Purchase And Sale
-0.06
+86.68%
-0.42
+85.96%
-2.98
-4744.88%
-0.06
Purchase Of PPE
-0.06
+86.68%
-0.42
+85.96%
-2.98
-3913.36%
-0.07
Sale Of PPE
—
—
0.00
-100.00%
0.01
Capital Expenditure
-0.15
+87.94%
-1.27
+86.18%
-9.17
-2293.21%
-0.38
Net Investment Purchase And Sale
—
—
0.00
+100.00%
-0.00
Purchase Of Investment
—
—
0.00
+100.00%
-0.00
Net Business Purchase And Sale
—
0.00
+100.00%
-5.23
0.00
Purchase Of Business
—
0.00
+100.00%
-5.23
0.00
Net Intangibles Purchase And Sale
-0.10
+88.56%
-0.85
+86.28%
-6.19
-1903.96%
-0.31
Purchase Of Intangibles
-0.10
+88.56%
-0.85
+86.28%
-6.19
-1903.96%
-0.31
Net Other Investing Changes
-1.86
-497.04%
0.47
-26.49%
0.64
+81.52%
0.35
Financing Cash Flow
14.06
+178.52%
5.05
-60.24%
12.69
-63.78%
35.05
Cash Flow From Continuing Financing Activities
14.06
+178.52%
5.05
-60.24%
12.69
-63.78%
35.05
Net Issuance Payments Of Debt
10.47
+1809.58%
0.55
+2660.45%
-0.02
+99.85%
-13.86
Issuance Of Debt
39.06
+45.63%
26.83
+26.23%
21.25
-19.90%
26.53
Repayment Of Debt
-28.60
-8.82%
-26.28
-23.53%
-21.27
+47.33%
-40.39
Long Term Debt Issuance
11.16
+1188.79%
0.87
-18.15%
1.06
+117.11%
0.49
Long Term Debt Payments
-1.89
-67.83%
-1.13
+35.20%
-1.74
+86.73%
-13.10
Net Long Term Debt Issuance
9.26
+3641.51%
-0.26
+61.65%
-0.68
+94.59%
-12.62
Short Term Debt Issuance
27.91
+7.51%
25.96
+28.55%
20.19
-22.47%
26.04
Short Term Debt Payments
-26.70
-6.18%
-25.15
-28.76%
-19.53
+28.41%
-27.29
Net Short Term Debt Issuance
1.21
+48.82%
0.81
+22.59%
0.66
+153.23%
-1.24
Net Common Stock Issuance
5.42
+734.68%
0.65
-93.44%
9.90
-71.94%
35.28
Common Stock Payments
—
0.00
+100.00%
-0.10
0.00
Repurchase Of Capital Stock
—
0.00
+100.00%
-0.10
0.00
Proceeds From Stock Option Exercised
0.00
-100.00%
4.24
+20.01%
3.53
-67.36%
10.83
Net Other Financing Charges
-1.83
-367.46%
-0.39
+45.45%
-0.72
+77.53%
-3.19
Changes In Cash
3.59
+203.60%
-3.47
+79.23%
-16.70
-182.86%
20.16
Effect Of Exchange Rate Changes
-0.45
-807.27%
-0.05
+76.90%
-0.21
-169.74%
0.31
Beginning Cash Position
0.32
-91.78%
3.83
-81.53%
20.75
+7142.80%
0.29
End Cash Position
3.46
+998.01%
0.32
-91.78%
3.83
-81.53%
20.75
Free Cash Flow
-8.60
+4.27%
-8.98
+63.78%
-24.80
-62.61%
-15.25
Interest Paid Supplemental Data
0.95
+34.38%
0.70
+73.23%
0.41
-30.81%
0.59
Income Tax Paid Supplemental Data
0.00
0.00
0.00
0.00
Change In Income Tax Payable
—
0.00
+100.00%
-0.13
+88.37%
-1.11
Change In Interest Payable
0.55
+689.10%
0.07
+159.71%
-0.12
+87.33%
-0.91
Change In Tax Payable
—
0.00
+100.00%
-0.13
+88.37%
-1.11
Common Stock Issuance
5.42
+734.68%
0.65
-93.51%
10.00
-71.65%
35.28
Issuance Of Capital Stock
5.42
+734.68%
0.65
-93.51%
10.00
-75.77%
41.28
Net Preferred Stock Issuance
—
—
0.00
-100.00%
6.00
Preferred Stock Issuance
—
—
0.00
-100.00%
6.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category